pharmaceutical Market Research Report Share Analysis of Global Acne Treatment Market 2 | Page 2

Description
Scope of the Report The report titled “ Global Acne Treatment Market : Trends and Opportunities ( 2014-2019 )” provides an insight into the acne market with focus on global prescription drugs . The report assesses the market sizing and growth of the global acne market , the growth of acne market in various regions and the growth and composition of oral and topical acne drugs . The report further analyzes the major prescription drugs for the treatment of acne . The report also discusses key factors driving growth of the industry , major trends and challenges faced by manufacturers of acne drugs . Further , key players like Foamix Pharmaceuticals , Valeant Pharmaceuticals , Dermira and Actavis Plc are analyzed in the report .
Purchase a copy of Global Acne Treatment Market visit @ http :// www . orbisresearch . com / contact / purchase / 185255 For more information contact sales @ orbisresearch . com .
Product Coverage Anti-Acne Drugs Solodyn Doryx Epiduo Absorica Aczone
Regional Coverage United States Europe Asia Pacific Japan
Company Coverage Foamix Pharmaceuticals HELLA Valeant Pharmaceuticals Dermira Actavis Plc
Request a sample of this report @ http :// www . orbisresearch . com / contacts / request-sample / 185255 .
Executive Summary The global acne market represents a small fraction of total dermatology market and both over the counter drugs and prescription drugs are used to treat acne . The acne market is primarily genericised and is moderately served by the currently marketed major prescribed drugs including SOLODYN , DORYX , and EPIDUO . The US market is the largest market for the global acne products with about 50 million suffering from acne in the country . Globally , acne market is of very small size but holds immense potential driven mostly by growing income of individuals , rising health expenditures , increased fast food consumption and increased spending on
www . orbisresearch . com ; + 1 ( 214 ) 884-6817 ; + 9120-64101019